Patents by Inventor Martin Gohlke

Martin Gohlke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR QUANTIFYING CPG-CONTAINING OLIGONUCLEOTIDES IN COMPOSITIONS COMPRISING ALUM
    Publication number: 20240027434
    Abstract: The present disclosure relates to methods for characterizing formulations comprising aluminum hydroxide particles (alum), an antigen bound to the alum, and an unmethylated cytidine-phospho-guanosine-containing oligodeoxynucleotide (CpG ODN). In particular, the present disclosure provides methods for determining concentration of CpG ODN in a vaccine formulation through use of a colorimetric assay for measuring total phosphorus.
    Type: Application
    Filed: December 14, 2021
    Publication date: January 25, 2024
    Applicant: Dynavax Technologies Corporation
    Inventor: Martin GOHLKE
  • ACTIVE BOOSTER IMMUNIZATION AGAINST TETANUS, DIPHTHERIA AND PERTUSSIS
    Publication number: 20230072809
    Abstract: The present disclosure relates to immunogenic compositions comprising tetanus, diphtheria, and acellular pertussis (Tdap) antigens, and a toll-like receptor 9 (TLR9) agonist, such as oligonucleotide comprising an unmethylated cytidine-phospho-guanosine (CpG) motif. The immunogenic compositions may further comprise an aluminum salt adjuvant to which the Tdap antigens are adsorbed. The immunogenic compositions are suitable for active booster immunization against tetanus, diphtheria, and pertussis in an individual in need thereof.
    Type: Application
    Filed: March 9, 2021
    Publication date: March 9, 2023
    Applicants: Dynavax Technologies Corporation, Serum Institute of India Private Limited
    Inventors: John D. CAMPBELL, Robert L. COFFMAN, Randall N. HYER, Robert S. JANSSEN, David NOVACK, Martin GOHLKE, Maureen URBAN, Sunil GAIROLA, Umesh SHALLIGRAM, Manish GAUTUM, Harish RAO
  • Recombinant glycoproteins, method for the production thereof, medicaments containing said glycoproteins and use thereof
    Patent number: 6692931
    Abstract: The invention relates to novel recombinant glycoproteins that act as messenger substances, signaling substances, promoters, stimulators and initiators in a multitude of ways in the animal, especially human, circulation system.
    Type: Grant
    Filed: December 13, 2001
    Date of Patent: February 17, 2004
    Inventors: Werner Reutter, Rudolf Tauber, Rüdiger Horstkorte, Sabine Nöhring, Martin Gohlke, Rolf Nuck, Richard R. Schmidt, Charlotte Hauser